Increased memory b cell potency and breadth after a sars-cov-2 mrna boost

HIGHLIGHTS

• who: Frauke Muecksch from the Study participants Participants were healthy volunteers who had previously received the initial two-dose regimen of either the Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) mRNA vaccine against the WT (Wuhan-Hu-1) strain of SARS-CoV- For this study, participants were recruited for serial blood donations at The Rockefeller University Hospital in New York between , January and , December, . No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. The majority of participants (n=32 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.